NOVARTIS AG
Business
Novartis AG is an innovative medicines company that researches, develops, manufactures, markets and sells pharmaceutical and advanced therapy products. It offers a broad portfolio of prescription medicines, gene and cell therapies, radioligand therapies, siRNA and other RNA-based treatments, biologics and small-molecule drugs across multiple therapeutic areas. Its operations are organized into Biomedical Research, Development, Operations and two commercial units (US and International), supported by global corporate functions. Novartis sells products in approximately 120 countries through wholesalers, hospitals, specialty pharmacies, managed care organizations, government agencies and direct-to-patient channels.
Summary from filing dated 2026-02-04
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $13.97B |
| Total assets | $110.95B |
| Total liabilities | $64.40B |
| Stockholders' equity | — |
| Operating cash flow | — |